Laurent Cotte

机构：Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Hôpital Pellegrin, Médecins du Monde, Hôpital Paul-Brousse

发表论文 246 篇 · 总被引 7605 次 · h-index 41

代表论文

• Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial (2019 · The Lancet HIV · 被引 101)
• On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial (2019 · The Lancet HIV · 被引 79)
• Evolocumab in HIV-Infected Patients With Dyslipidemia (2020 · Journal of the American College of Cardiology · 被引 63)
• Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study (2020 · Journal of Antimicrobial Chemotherapy · 被引 40)
• Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 (2019 · Antiviral Research · 被引 36)
• Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials (2023 · The Lancet HIV · 被引 35)